News

KORU Medical Systems Partners for Innovative Infusion Solutions

KORU Medical Systems Partners for Innovative Infusion Solutions

KORU Medical Systems Partners for Innovative Infusion Solutions

KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology firm, is making strides in the realm of healthcare by announcing a new partnership with a global pharmaceutical company. This agreement aims to develop and receive regulatory approval for a groundbreaking subcutaneous immunoglobulin (SCIg) therapy infusion system tailored for a recently commercialized drug therapy. This collaboration represents a significant move towards enhancing patient-centered healthcare solutions.

A Vision for Enhanced Patient Care

The initiative involves a collaborative effort with SCHOTT Pharma, intending to serve as a cornerstone for future projects. By partnering with SCHOTT Pharma, KORU Medical aspires to create a multifaceted infusion system configurable with both vials and prefilled syringes. Harnessing KORU Medical's advanced infusion technology alongside SCHOTT's pioneering TOPPAC® prefillable polymer syringes (PFS), this project is poised to set new standards in the infusion realm.

Transformative Infusion Technology

Linda Tharby, President and CEO of KORU Medical, highlighted the significance of this collaboration, stating that it represents another milestone in their mission to improve the infusion experience for SCIg patients. She emphasized the necessity for an easy-to-use delivery system that fits seamlessly into patients' lives, fostering better adherence to treatment regimens.

The Freedom System: A Beacon of Innovation

KORU Medical has a solid foundation in providing innovative medical solutions. The company’s flagship product, the FREEDOM Syringe Infusion System, encompasses technologies such as the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers. This system is designed for self-administration at home and is also suitable for use in ambulatory infusion centers, showcasing its versatility in diverse healthcare settings.

Empowering Patients with Advanced Solutions

With FDA clearance received in 1994, the Freedom System has evolved significantly, consistently improving the quality of life for patients worldwide. Its design emphasizes user-friendliness, making it an ideal choice for individuals requiring home therapy. The system also encompasses customization capabilities, allowing KORU Medical to tailor solutions for biopharmaceutical companies involved in clinical trials.

Looking Forward: A Commitment to Patient-Centric Innovation

As KORU Medical embarks on this new project, their commitment to patient-centered principles remains at the forefront. The company aims not just to improve healthcare delivery but also to foster a sense of empowerment among patients who rely on their innovations for daily treatment. By integrating new formats such as prefilled syringes, KORU Medical strives to enhance the convenience and efficacy of therapies.

Collaborative Endeavors for Future Projects

The partnership with SCHOTT Pharma marks the beginning of a promising journey filled with potential. KORU Medical envisions this as the first of many initiatives that will combine insights from both organizations to enhance infusion technologies further. Ultimately, this collaboration intends to refine the patient experience and bring innovative solutions to a larger audience.

Frequently Asked Questions

What is the primary goal of KORU Medical's new agreement?

The primary goal is to develop a next-generation subcutaneous immunoglobulin infusion system for commercialized drug therapy.

How will SCHOTT Pharma be involved in this project?

SCHOTT Pharma will collaborate closely with KORU Medical to create an infusion system that can work with both vials and prefilled syringes.

What products does KORU Medical currently offer?

KORU Medical offers the FREEDOM Syringe Infusion System, which includes FREEDOM60® and FreedomEdge® Syringe Infusion Drivers.

When did KORU Medical receive FDA clearance for their Freedom System?

KORU Medical received FDA clearance for the Freedom System in 1994.

What does the company emphasize in its mission?

KORU Medical emphasizes providing innovative, patient-centric solutions that improve quality of life for individuals managing their health.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 0

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 3

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 1

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 1

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 0

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 3

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 0

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading

Top 5 Most Recently Viewed Articles

Cohu's Strategic Market Entry Fuels Growth Amidst Challenges

Updated Category News Views 138

Cohu's Resilient Q3 Performance Highlights Cohu, Inc. (NASDAQ: COHU), a prominent supplier in semiconductor testing and inspection, recently reported its financial results for Q3 2024. The company's revenue stood at $95.3 million, reflecting a gross margin of 47%, showcasing a strong foundation with 67% of its revenue derived from recurring sources. This resilient...

Continue Reading
Prime Healthcare Achieves Remarkable Honors for Heart and Stroke Care

Updated Category News Views 108

Prime Healthcare's Dedication to Quality Care Prime Healthcare has recently celebrated a significant achievement, receiving recognition for its outstanding treatment of heart failure and strokes. The American Heart Association awarded 23 hospitals within the Prime Healthcare network with the prestigious Get With The Guidelines® - Heart Failure Award, highlighting their...

Continue Reading
Investigation of Endeavour Silver Corp. Claims by Pomerantz LLP

Updated Category News Views 44

Pomerantz LLP Investigates Claims Against Endeavour Silver Corp. Pomerantz LLP is actively investigating claims on behalf of investors in Endeavour Silver Corp. (NYSE: EXK). If you have invested in this company, it’s crucial to stay updated on recent developments and what they could mean for your investment. Details of the Investigation This investigation centers on...

Continue Reading
Exploring the Future of 5G Device Testing: Key Market Trends

Updated Category News Views 206

Growth and Developments in the 5G Device Testing Market The 5G Device Testing market has shown remarkable growth, with its expected value reaching USD 2.59 billion by 2032, up from USD 1.40 billion in 2023. This growth, estimated at a CAGR of 7.10%, reflects the increasing complexity of devices and the evolving standards governing connectivity and performance. As...

Continue Reading
Analyzing Short Interest Trends for CACI International Inc Shares

Updated Category News Views 152

Understanding Short Selling and Its Significance CACI International Inc's (NYSE: CACI) short interest as a percentage of floating shares has increased significantly. Recently, it was noted that the short interest has risen by 9.87%, with approximately 1.18 million shares sold short. This accounts for around 6.79% of all the shares available for trading on a regular basis....

Continue Reading